Holen Sie sich die Stockscreener-App
0.96
1.13%
-0.0311
Genenta Science Spa Adr Aktie (GNTA) Neueste Nachrichten
Genenta Science (NASDAQ: GNTA) Transitions Strategy Following Full Acquisition of A.T.C. - Kalkine Media
Genenta Science Accelerates Shift to Aerospace and Defense With Industrial Consolidation Strategy - TipRanks
Enterprise value to EBITDA forward of Genenta Science SpA Sponsored ADR – MUN:K5F - TradingView
Genenta Science Shareholders Approve Major Capital Authorization and Reverse Split Plan - TipRanks
Genenta Science SpA Sponsored ADR Revenue Breakdown – MUN:K5F - TradingView
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm - GlobeNewswire Inc.
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm - Barchart.com
Genenta-backed Sòphia sales rise 29.3% to €7.17 million - grafa.com
The market is filled with gapping stocks in Wednesday's session. - ChartMill
Genenta Science Regains Full Effectiveness of Corporate Purpose Amendment After Milan Court Ruling - TipRanks
Genenta Science Confirms New Board, Share Buyback and Closes Sòphia High Tech Deal - TipRanks
GENENTA SCIENCE SPAADR (GNTA) Stock Chart - ChartMill
Enterprise value to EBITDA forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to EBIT forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to revenue forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Price to earnings forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands - The Globe and Mail
Genenta Science SpA Sponsored ADR Actuals & Estimates (NASDAQ:GNTA) - TradingView
Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026 - The Globe and Mail
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split - The Globe and Mail
Genenta Science regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com Australia
Genenta Science regains compliance with Nasdaq minimum bid price rule - Investing.com
Genenta Science Regains Compliance with Nasdaq Minimum Bid Price Rule - TipRanks
Genenta sale al 100% della brianzola Atc (fucili per le forze speciali) e nomina il generale Luca Goretti nel cda - Milano Finanza
Unusual volume stocks in Tuesday's session - ChartMill
Which stocks have an unusual volume on Monday? - ChartMill
Which stocks are moving on Monday? - ChartMill
Monday's session: gap up and gap down stocks - ChartMill
Wondering what's happening in today's pre-market session? - ChartMill
Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C. - The Globe and Mail
GNTAGenenta Science SpA ADR Options - Finviz
On Friday, there are stocks with unusual volume. Let's take a look. - ChartMill
Wondering what's happening in today's after-hours session? - ChartMill
GNTA Stock Price, Quote & Chart | GENENTA SCIENCE SPAADR (NASDAQ:GNTA) - ChartMill
Genenta Science Ends Ospedale San Raffaele License to Refocus Strategy - TipRanks
Genenta Science to Close U.S. Subsidiary and Shift CFO to Consulting Role - The Globe and Mail
Genenta Science to close US subsidiary and transition CFO to consulting role - Investing.com Canada
Genenta Science to close US subsidiary and transition CFO to consulting role By Investing.com - Investing.com South Africa
Unusual VolumeStock ScreenerNews - Finviz
Genenta Science Moves Into Aerospace With Majority Investment Deal for Sòphia High Tech - The Globe and Mail
Genenta signs Definitive Agreements with Sophia High Tech - Barchart.com
Genenta Science Warned by Nasdaq Over Minimum Bid Price Compliance - The Globe and Mail
Genenta Science receives Nasdaq notice on minimum bid price compliance By Investing.com - Investing.com India
Genenta Science receives Nasdaq notice on minimum bid price compliance - Investing.com
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):